Clinical and pharmacokinetic study of 96-h infusions of doxorubicin in advanced cancer patients
- 1 March 1989
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 25 (3), 505-511
- https://doi.org/10.1016/0277-5379(89)90264-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Pharmacokinetics of doxorubicin in sarcoma patientsEuropean Journal of Clinical Pharmacology, 1987
- Continuous Infusion or Intravenous Bolus: What Is the Rationale for Doxorubicin Administration?Cancer Drug Delivery, 1987
- Optimal schedule for anthracyclinesEuropean Journal of Cancer and Clinical Oncology, 1985
- Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancerCancer, 1982
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Extraction of Anthracyclines from Biological Fluids for HPLC EvaluationJournal of Liquid Chromatography, 1980
- Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological FluidsJournal of Liquid Chromatography, 1978
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- Progress in the Treatment of Adults With Acute LeukemiaArchives of Internal Medicine, 1976